These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27480131)

  • 1. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention in familial adenomatous polyposis: past, present and future.
    Kemp Bohan PM; Mankaney G; Vreeland TJ; Chick RC; Hale DF; Cindass JL; Hickerson AT; Ensley DC; Sohn V; Clifton GT; Peoples GE; Burke CA
    Fam Cancer; 2021 Jan; 20(1):23-33. PubMed ID: 32507936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
    Ulusan AM; Rajendran P; Dashwood WM; Yavuz OF; Kapoor S; Gustafson TA; Savage MI; Brown PH; Sei S; Mohammed A; Vilar E; Dashwood RH
    Cancer Prev Res (Phila); 2021 Mar; 14(3):325-336. PubMed ID: 33277315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary chemoprevention of familial adenomatous polyposis with sulindac.
    Giardiello FM; Yang VW; Hylind LM; Krush AJ; Petersen GM; Trimbath JD; Piantadosi S; Garrett E; Geiman DE; Hubbard W; Offerhaus GJ; Hamilton SR
    N Engl J Med; 2002 Apr; 346(14):1054-9. PubMed ID: 11932472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.
    Giardiello FM; Spannhake EW; DuBois RN; Hylind LM; Robinson CR; Hubbard WC; Hamilton SR; Yang VW
    Dig Dis Sci; 1998 Feb; 43(2):311-6. PubMed ID: 9512123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.
    Delker DA; Wood AC; Snow AK; Samadder NJ; Samowitz WS; Affolter KE; Boucher KM; Pappas LM; Stijleman IJ; Kanth P; Byrne KR; Burt RW; Bernard PS; Neklason DW
    Cancer Prev Res (Phila); 2018 Jan; 11(1):4-15. PubMed ID: 29109117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.
    Mackenzie GG; Ouyang N; Xie G; Vrankova K; Huang L; Sun Y; Komninou D; Kopelovich L; Rigas B
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1052-60. PubMed ID: 21464038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
    Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
    Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
    Burn J; Mathers J; Bishop DT
    Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates in chemoprevention research for hereditary gastrointestinal and polyposis syndromes.
    Hall MJ
    Curr Treat Options Gastroenterol; 2021 Mar; 19(1):30-46. PubMed ID: 34211259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of colon crypt stem cell dynamics in sulindac treated Familial Adenomatous Polyposis patients.
    Ma H; Brosens LAA; Elias SG; Morsink FHM; Nijman IJ; Hylind LM; Montgomery EA; Offerhaus GJA; Giardiello FM; de Leng WWJ
    Sci Rep; 2017 Sep; 7(1):11972. PubMed ID: 28931879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which Drugs are More Effective in Preventing Familial Adenomatous Polyposis Progression based on Network Meta-analysis?
    Luo P; Shi W; Cheng X; Yang J; Pei G; Dong J
    Curr Pharm Des; 2024; 30(20):1548-1563. PubMed ID: 38698755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of metformin in familial adenomatous polyposis and the effect of intestinal flora.
    Zhou L; Zheng L; Xu B; Ye Z; Li D; Wang W
    Orphanet J Rare Dis; 2024 Feb; 19(1):88. PubMed ID: 38403687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eflornithine for chemoprevention in the high-risk population of colorectal cancer: a systematic review and meta-analysis with trial sequential analysis.
    Yang L; Wang Y; Hu S; Wang X
    Front Oncol; 2023; 13():1281844. PubMed ID: 38033490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer in Patients With Familial Adenomatous Polyposis: A Nationwide Danish Cohort Study With Matched Controls.
    Karstensen JG; Bülow S; Højen H; Jelsig AM; Jespersen N; Andersen KK; Wewer MD; Burisch J; Pommergaard HC
    Gastroenterology; 2023 Sep; 165(3):573-581.e3. PubMed ID: 37201686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of duodenal neoplasia to advanced adenoma in patients with familial adenomatous polyposis.
    Nakahira H; Takeuchi Y; Shimamoto Y; Ishiguro S; Yunokizaki H; Ezoe Y; Fujisawa F; Ishihara R; Takayama T; Yoshida T; Mutoh M; Ishikawa H
    Hered Cancer Clin Pract; 2023 Nov; 21(1):25. PubMed ID: 38012770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase II trial of sulindac for lung cancer chemoprevention.
    Limburg PJ; Mandrekar SJ; Aubry MC; Ziegler KL; Zhang J; Yi JE; Henry M; Tazelaar HD; Lam S; McWilliams A; Midthun DE; Edell ES; Rickman OB; Mazzone P; Tockman M; Beamis JF; Lamb C; Simoff M; Loprinzi C; Szabo E; Jett J;
    Lung Cancer; 2013 Mar; 79(3):254-61. PubMed ID: 23261228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physical fitness on colorectal tumor development in patients with familial adenomatous polyposis.
    Nakamura T; Ishikawa H; Sakai T; Ayabe M; Wakabayashi K; Mutoh M; Matsuura N
    Medicine (Baltimore); 2019 Sep; 98(38):e17076. PubMed ID: 31567943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow progression of periampullary neoplasia in familial adenomatous polyposis.
    Moozar KL; Madlensky L; Berk T; Gallinger S
    J Gastrointest Surg; 2002; 6(6):831-7; discussion 837. PubMed ID: 12504221
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.